To examine the therapeutic relevance of these findings, the authors prepared chitosan nanoparticles loaded with a galectin-1-specific siRNA which were administered intranasally to mice transplanted with GL261 glioma cells. This evidence concerns the gene LGALS1 and central nervous system cancer.